Advertisements




Pharma Stock Roundup: Roche to Buy ONCE, Lawmakers Grill CEOs Over High Drug Prices

Zacks.....»»

Category: topSource: redinewsMar 1st, 2019

Pharma Stock Roundup: Zoetis to Buy Abaxis, NVS Gets FDA Nod for Migraine Drug

Zacks.....»»

Category: topSource: redinewsMay 19th, 2018

Pharma Stock Roundup: JNJ & NVS" Q2 Earnings, FDA Approvals

J&J (JNJ) and Novartis (NVS) kick off earnings for pharma sector on a strong note. FDA approves J&J's latest HIV medicine and line extension of Pfizer's prostate cancer drug. .....»»

Category: personnelSource: nytJul 20th, 2018

Defense Stock Roundup: US-Canada Trade Talk, BA"s Deal Wins, AOBC Earnings in Focus

Zacks.....»»

Category: topSource: redinewsSep 3rd, 2018

Merck Wins Yet Again With New Keytruda Approval

Merck shares were up slightly on Wednesday after the pharma giant gave another key update for its KEYTRUDA line. The firm announced that the U.S. Food and Drug Administration (FDA) has approved........»»

Category: blogSource: 247wallstOct 31st, 2018

Pharma Stock Roundup: AZN, RHHBY Cancer Drugs, LLY, BMY New Deals in Focus

Zacks.....»»

Category: topSource: redinewsDec 14th, 2018

Pharma Stock Roundup: Regulatory Updates in Focus at PFE, BMY, RHHBY, SNY

Zacks.....»»

Category: topSource: redinewsJan 18th, 2019

Will Patent Woes Boost Pharma Stock Megamergers Further?

With key drugs losing exclusivity, key drug makers are poised to face deep trouble since their sales are mostly dependent on a single drug. Want the latest recommendations from Zacks Investment Research? Today, you can download 7.....»»

Category: worldSource: nytJul 10th, 2019

Pharma Stock Roundup: PFE"s Regulatory/Pipeline Updates, CHMP Nod for Several Drugs

Zacks.....»»

Category: topSource: redinewsJul 5th, 2019

Cytori CFO Resigns, Biotech Restructures In Bid To Focus Resources On Lung Cancer Drug

Thinly traded nano-cap biotech Cytori Therapeutics Inc (NASDAQ: CYTX), which has been trading in penny stock territory for about a year now, could see some activity in the wake of a company announcement Friday.  read more.....»»

Category: blogSource: benzingaJul 5th, 2019

The Daily Biotech Pulse: Celyad To Advance Leukemia Drug To Clinical Trial, Positive Data For Teva"s Migraine Drug

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 1) read more.....»»

Category: blogSource: benzingaJul 2nd, 2019

Airline Stock Roundup: DAL"s Impressive May Traffic Report, AAL, LUV in Focus

Zacks.....»»

Category: topSource: redinewsJun 6th, 2019

Catalyst Pharma stock plummets after FDA approves competitor"s drug

Catalyst Pharmaceuticals Inc. shares plunged more than 40% in after-hours trading Monday afternoon, when the Food and Drug Administration appro.....»»

Category: topSource: marketwatchMay 6th, 2019

Better Big Pharma Stock: AbbVie vs. AstraZeneca

These A-list drugmakers must both contend with expiring patents, new drug uncertainties, and hungry competitors. But they're in different stages of their cyclical journeys......»»

Category: topSource: foxnewsApr 29th, 2019

The Daily Biotech Pulse: Mixed Results For Merck"s Keytruda In Stomach Cancer; Roche"s Spark-Buy Delayed, Teva Recalls Hypertension Drug

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on April 25) read more.....»»

Category: blogSource: benzingaApr 26th, 2019

Airline Stock Roundup: UAL, JBLU & HA Earnings Beat, ALGT in Focus

We expect passenger revenues to grow for airline companies that are schedu.....»»

Category: dealsSource: nytApr 24th, 2019

The Daily Biotech Pulse: Merck"s Keytruda Clinches Another FDA Win, KemPharm Close To NDA Filing For ADHD Drug

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week hig.....»»

Category: earningsSource: benzingaApr 12th, 2019

The Daily Biotech Pulse: Merck"s Keytruda Clinches Another FDA Win, KemPharm Close To NDA Filing For ADHD Drug

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on April 11) read more.....»»

Category: blogSource: benzingaApr 12th, 2019

Why Recro Pharma"s stock price plunged more than 34% today

Recro Pharma's stock price plummeted more than 34 percent to $6.41 per share Monday, the first day of trading after the Food and Drug Administration's rejection of the Malvern pharmaceutical company's new drug application for a non-opioid pain medic.....»»

Category: topSource: bizjournalsMar 25th, 2019

Recro Pharma"s stock plunges to pace premarket decliners after 2nd CRL for pain treatment

Shares of Recro Pharma Inc. plummeted 46% to pace all premarket decliners Monday, after the specialty pharmaceutical company said it received a second "complete response letter" (CRL) from the Food and Drug Administ.....»»

Category: topSource: marketwatchMar 25th, 2019